Your browser doesn't support javascript.
loading
Consequences of PDGFRα+ fibroblast reduction in adult murine hearts.
Kuwabara, Jill T; Hara, Akitoshi; Bhutada, Sumit; Gojanovich, Greg S; Chen, Jasmine; Hokutan, Kanani; Shettigar, Vikram; Lee, Anson Y; DeAngelo, Lydia P; Heckl, Jack R; Jahansooz, Julia R; Tacdol, Dillon K; Ziolo, Mark T; Apte, Suneel S; Tallquist, Michelle D.
Afiliação
  • Kuwabara JT; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Hara A; Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Bhutada S; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Gojanovich GS; Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, United States.
  • Chen J; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Hokutan K; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Shettigar V; Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Lee AY; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • DeAngelo LP; Dorothy M. Davis Heart and Lung Research Institute, Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, United States.
  • Heckl JR; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Jahansooz JR; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Tacdol DK; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Ziolo MT; Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Apte SS; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
  • Tallquist MD; Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, United States.
Elife ; 112022 09 23.
Article em En | MEDLINE | ID: mdl-36149056
ABSTRACT
Fibroblasts produce the majority of collagen in the heart and are thought to regulate extracellular matrix (ECM) turnover. Although fibrosis accompanies many cardiac pathologies and is generally deleterious, the role of fibroblasts in maintaining the basal ECM network and in fibrosis in vivo is poorly understood. We genetically ablated fibroblasts in mice to evaluate the impact on homeostasis of adult ECM and cardiac function after injury. Fibroblast-ablated mice demonstrated a substantive reduction in cardiac fibroblasts, but fibrillar collagen and the ECM proteome were not overtly altered when evaluated by quantitative mass spectrometry and N-terminomics. However, the distribution and quantity of collagen VI, microfibrillar collagen that forms an open network with the basement membrane, was reduced. In fibroblast-ablated mice, cardiac function was better preserved following angiotensin II/phenylephrine (AngII/PE)-induced fibrosis and myocardial infarction (MI). Analysis of cardiomyocyte function demonstrated altered sarcomere shortening and slowed calcium decline in both uninjured and AngII/PE-infused fibroblast-ablated mice. After MI, the residual resident fibroblasts responded to injury, albeit with reduced proliferation and numbers immediately after injury. These results indicate that the adult mouse heart tolerates a significant degree of fibroblast loss with a potentially beneficial impact on cardiac function after injury. The cardioprotective effect of controlled fibroblast reduction may have therapeutic value in heart disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor alfa de Fator de Crescimento Derivado de Plaquetas / Infarto do Miocárdio Limite: Animals Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor alfa de Fator de Crescimento Derivado de Plaquetas / Infarto do Miocárdio Limite: Animals Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos